According to Spectrum Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 201,918,066. At the end of 2023 the company had 201,918,066 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.20 B | 1.19% |
2022 | 0.19 B | 29% |
2021 | 0.15 B | 9.37% |
2020 | 0.14 B | 27.01% |
2019 | 0.11 B | 5.42% |
2018 | 0.10 B | 7.39% |
2017 | 98.36 M | 25.47% |
2016 | 78.4 M | 19.93% |
2015 | 65.37 M | 0.49% |
2014 | 65.05 M | 3.5% |
2013 | 62.85 M | 7.2% |
2012 | 58.62 M | 8.96% |
2011 | 53.81 M | 8.18% |
2010 | 49.73 M | 17.41% |
2009 | 42.36 M | 34.33% |
2008 | 31.53 M | 1.62% |
2007 | 31.03 M | 26.75% |
2006 | 24.48 M | 46.91% |
2005 | 16.66 M | 18.51% |
2004 | 14.06 M | 253.77% |
2003 | 3.97 M | 154.07% |
2002 | 1.56 M | 122.49% |
2001 | 0.7 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 2,598,734,075 | 1,187.02% | ๐บ๐ธ USA |
![]() Novartis NVS | 2,083,000,000 | 931.61% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | 5,634,000,000 | 2,690.24% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | 1,738,946,799 | 761.21% | ๐บ๐ธ USA |
![]() Biogen BIIB | 144,400,000 | -28.49% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | 2,099,000,000 | 939.53% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | 2,022,000,000 | 901.40% | ๐ฌ๐ง UK |
![]() Seagen
SGEN | 186,889,000 | -7.44% | ๐บ๐ธ USA |
![]() Curis CRIS | 96,613,544 | -52.15% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | 1,115,000,000 | 452.20% | ๐ฎ๐ฑ Israel |